glp 1 approved for nash Frontiers Treatment with a GLP-1R agonist

But as key patents begin approaching expiry over the coming years, a new phase is unfolding the generics and biosimilar race

According to PharmaTrac data., Mounjaro launched in March last year, added Rs.105 crore in December, taking its total sales to Rs.600 crore in sales, reflecting rapid uptake despite hardly any insurance coverage and outofpocket affordability constraints.

The most used medications were semaglutide (54%), liraglutide (39%), and tirzepatide (7%)

injections: Do patches work for weight loss

As low-price gyms race to expand, Crunch is investing in community and AI-powered technology to keep members engaged for the long haul.

Glucagon-like peptide (GLP)-1 receptor agonists are the cornerstone in the treatment of hyperglycemia in many people suffering from type 2 diabetes (T2D)